Patents Assigned to ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
  • Laser-based vaccine adjuvants
    Patent number: 10052376
    Abstract: The invention is directed to a vaccine for generating an enhanced immune response in a subject previously exposed to non-destructive laser radiation, as compared to an immune response in a subject previously non-exposed to non-destructive laser radiation. The invention is also directed to use of a composition comprising a vaccine for use in combination with non-destructive laser radiation for generating an enhanced immune response from a subject, as compared to an immune response without the use of laser radiation. The laser exposure acts as an adjuvant for the vaccine, increasing the efficacy and/or potency of the vaccine.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: August 21, 2018
    Assignee: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergey B. Onikienko, Alexander V. Zemlyanoi, Boris A. Margulis, Irina V. Guzhova, Anna A. Pimenova
  • Degradation resistant HSP70 formulations and uses thereof
    Patent number: 9937241
    Abstract: The present invention relates to novel therapies that utilize stabilized exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of degradation resistant formulations of HSP70. Furthermore, the present invention is directed to methods comprising the administration of stabilized exogenous HSP70 for use in the treatment of HSP70 related disorders or conditions, for example, for increased endurance or alleviating fatigue syndrome.
    Type: Grant
    Filed: October 13, 2012
    Date of Patent: April 10, 2018
    Assignee: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B Onikienko, Alex Nivorozhkin
  • Methods of use of HSP70 for increased performance or treatment of HSP70 related disorders
    Patent number: 9616100
    Abstract: The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: April 11, 2017
    Assignee: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B Onikienko, Alex Nivorozhkin, Alexander V Zemlyanoi
  • NOVEL METHODS OF USE OF HSP70 FOR INCREASED PERFORMANCE OR TREATMENT OF HSP70 RELATED DISORDERS
    Publication number: 20140329764
    Abstract: The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
    Type: Application
    Filed: July 16, 2014
    Publication date: November 6, 2014
    Applicant: Alternative Innovative Technologies LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin, Alexander V. Zemlyanoi
  • HSP70 FUSION PROTEIN CONJUGATES AND USES THEREOF
    Publication number: 20130156694
    Abstract: The present invention relates to novel therapies that utilize HSP70 fusion proteins for the treatment of disorders or conditions regulated by HSP70.
    Type: Application
    Filed: December 15, 2012
    Publication date: June 20, 2013
    Applicant: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin, Alexander V. Zemlyanoi, Mikhail Viktorovich Shorokhov, Vladimir Ivanovich Pereguda, Valery Aleksandrovich Chereshnev
  • DEGRADATION RESISTANT HSP70 FORMULATIONS AND USES THEREOF
    Publication number: 20130101573
    Abstract: The present invention relates to novel therapies that utilize stabilized exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of degradation resistant formulations of HSP70.
    Type: Application
    Filed: October 13, 2012
    Publication date: April 25, 2013
    Applicant: Alternative Innovative Technologies LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin
  • NOVEL METHODS OF USE OF HSP70 FOR INCREASED PERFORMANCE OR TREATMENT OF HSP70 RELATED DISORDERS
    Publication number: 20130090294
    Abstract: The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
    Type: Application
    Filed: June 28, 2012
    Publication date: April 11, 2013
    Applicant: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin, Alexander V. Zemlyanoi